KLI
BSX icon

Kelman-Lazarov Inc’s Boston Scientific BSX Stock Holding History

Kelman-Lazarov Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-757
Closed -$16.4K – 123
2016
Q4 		$16.4K Sell
757
-2,450
-76% -$53.5K 0.01% 228
2016
Q3 		$74.7K Hold
3,207
– – 0.04% 158
2016
Q2 		$75.1K Hold
3,207
– – 0.04% 155
2016
Q1 		$61K Buy
+3,207
New +$56.3K 0.04% 171

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Kelman-Lazarov Inc's BSX Position: Q1 2017 in Review

Kelman-Lazarov Inc sold out of Boston Scientific (BSX) in Q1 2017, closing a stake of 757 shares — an estimated $16.4K sold.

Kelman-Lazarov Inc first reported a position in BSX in Q1 2016 and held it in 4 quarters. The position peaked at $75.1K in Q2 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

  • Kelman-Lazarov Inc reported no remaining Boston Scientific position as of Q1 2017 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 757 Boston Scientific shares in Q1 2017, an estimated $16.4K.
  • Kelman-Lazarov Inc first reported a position in Boston Scientific in Q1 2016 and held it in 4 quarters.
  • Kelman-Lazarov Inc's Boston Scientific position peaked at $75.1K in Q2 2016.
  • 552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on Kelman-Lazarov Inc's 13F filing for Q1 2017, filed 25 Apr 2017.